title: Novel hepatocyte growth factor (HGF) binding domains on fibronectin and vitronectin coordinate a distinct and amplified Met-integrin induced signalling pathway in endothelial cells.
abstract: BACKGROUND
  The growth of new blood vessels in adult life requires the initiation of endothelial cell migration and proliferation from pre-existing vessels in addition to the recruitment and differentiation of circulating endothelial progenitor cells. Signals emanating from growth factors and the extracellular matrix are important in regulating these processes.
  
  
  RESULTS
  Here we report that fibronectin (FN) and vitronectin (VN) modulate the responses of endothelial cells to HGF (Scatter Factor), an important pro-angiogenic mediator. Novel binding sites for HGF were identified on both FN and VN that generate molecular complexes with enhanced biological activity and these were identified in the supernatants of degranulated platelet suspensions implicating their release and formation in vivo. In the absence of co-stimulation with an ECM glycoprotein, HGF could not promote endothelial cell migration but retained the capacity to induce a proliferative response utilising the Map kinase pathway. Through promoting Met-Integrin association, HGF-FN and HGF-VN complexes coordinated and enhanced endothelial cell migration through activation of the PI-3 kinase pathway involving a Ras-dependent mechanism whereas a Ras-independent and attenuated migratory response was promoted by co-stimulation of cells with HGF and a non-binding partner ECM glycoprotein such as collagen-1.
  
  
  CONCLUSIONS
  These studies identify a novel mechanism and pathway of HGF signalling in endothelial cells involving cooperation between Met and integrins in a Ras dependent manner. These findings have implications for the regulation of neovascularization in both health and disease.
authors.affiliation: Coagulation Research Laboratory, Division of Cardiovascular Medicine, GKT School of Medicine, St, Thomas' Hospital, London, UK. salman.rahman@kcl.ac.uk
authors.forename: Salman
authors.initials: S
authors.lastname: Rahman
authors.forename: Yatin
authors.initials: Y
authors.lastname: Patel
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Murray
authors.forename: Kirti V
authors.initials: KV
authors.lastname: Patel
authors.forename: Rushika
authors.initials: R
authors.lastname: Sumathipala
authors.forename: Michael
authors.initials: M
authors.lastname: Sobel
authors.forename: Errol S
authors.initials: ES
authors.lastname: Wijelath
mesh_terms: D001665:Binding Sites; D042783:Endothelial Cells / Q000166:cytology / Q000378:metabolism*; D004730:Endothelium, Vascular / Q000166:cytology; D005109:Extracellular Matrix; D005353:Fibronectins / Q000378:metabolism*; D006133:Growth Substances; D017228:Hepatocyte Growth Factor / Q000378:metabolism*; D006801:Humans; D016023:Integrins / Q000378:metabolism*; D018919:Neovascularization, Physiologic; D011518:Proto-Oncogene Proteins; D019859:Proto-Oncogene Proteins c-met; D017978:Receptors, Growth Factor; D015398:Signal Transduction; D019096:Vitronectin / Q000378:metabolism*
chemical_list: D005353:Fibronectins; D006133:Growth Substances; D016023:Integrins; D011518:Proto-Oncogene Proteins; D017978:Receptors, Growth Factor; D019096:Vitronectin; D017228:Hepatocyte Growth Factor; C491743:MET protein, human; D019859:Proto-Oncogene Proteins c-met
references.citation: Nature. 2000 Sep 14;407(6801):249-57
references.pmid: 11001068
references.citation: Int J Cancer. 1999 Nov 26;83(5):640-9
references.pmid: 10521801
references.citation: Am J Pathol. 2001 Mar;158(3):1111-20
references.pmid: 11238059
references.citation: J Biol Chem. 2001 Jun 1;276(22):19672-7
references.pmid: 11278592
references.citation: Cell. 2001 Nov 30;107(5):643-54
references.pmid: 11733063
references.citation: Cardiovasc Res. 2002 Jun;54(3):659-68
references.pmid: 12031712
references.citation: Circ Res. 2002 Jul 12;91(1):25-31
references.pmid: 12114318
references.citation: Nat Rev Cancer. 2002 Nov;2(11):826-35
references.pmid: 12415253
references.citation: J Biol Chem. 2002 Nov 15;277(46):43830-5
references.pmid: 12235151
references.citation: Circulation. 2003 Feb 4;107(4):524-30
references.pmid: 12566361
references.citation: J Biol Chem. 2003 May 16;278(20):18008-14
references.pmid: 12637493
references.citation: Mol Cell Biol. 2003 Aug;23(16):5726-37
references.pmid: 12897144
references.citation: J Cell Biol. 2003 Sep 1;162(5):933-43
references.pmid: 12952943
references.citation: Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12718-23
references.pmid: 14555767
references.citation: Circ Res. 2003 Nov 28;93(11):1066-73
references.pmid: 14576199
references.citation: Oncogene. 2003 Dec 8;22(56):9022-9
references.pmid: 14663480
references.citation: J Vasc Surg. 2004 Mar;39(3):655-60
references.pmid: 14981463
references.citation: Microvasc Res. 1977 Jul;14(1):53-65
references.pmid: 895546
references.citation: Nature. 1994 Aug 18;370(6490):527-32
references.pmid: 8052307
references.citation: EMBO J. 1996 May 15;15(10):2442-51
references.pmid: 8665852
references.citation: J Cell Biol. 1996 Dec;135(6 Pt 1):1633-42
references.pmid: 8978828
references.citation: Cell. 1997 May 2;89(3):457-67
references.pmid: 9150145
references.citation: Biochem J. 1997 Sep 15;326 ( Pt 3):891-5
references.pmid: 9307042
references.citation: EMBO J. 1997 Sep 15;16(18):5600-7
references.pmid: 9312019
references.citation: Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12419-24
references.pmid: 9356464
references.citation: J Cell Sci. 1998 Feb;111 ( Pt 4):469-78
references.pmid: 9443896
references.citation: Circulation. 1998 Feb 3;97(4):381-90
references.pmid: 9468212
references.citation: Exp Hematol. 1998 Aug;26(9):885-94
references.pmid: 9694510
references.citation: J Biol Chem. 1998 Nov 13;273(46):30336-43
references.pmid: 9804796
references.citation: EMBO J. 1999 Feb 15;18(4):882-92
references.pmid: 10022831
references.citation: J Cell Biol. 1999 May 17;145(4):889-97
references.pmid: 10330414
references.citation: J Biol Chem. 2000 Oct 27;275(43):33920-8
references.pmid: 10944524